195 related articles for article (PubMed ID: 30727920)
1. Novel 1,3,4-Triaryl Pyrazoles: Synthesis, QSAR Studies and Cytotoxicity against Breast Cancer.
Ismail MMF; Farrag AM; Harras MF
Anticancer Agents Med Chem; 2019; 19(7):948-959. PubMed ID: 30727920
[TBL] [Abstract][Full Text] [Related]
2. A novel series of pyrazole-platinum(II) complexes as potential anti-cancer agents that induce cell cycle arrest and apoptosis in breast cancer cells.
Czarnomysy R; Surażyński A; Muszynska A; Gornowicz A; Bielawska A; Bielawski K
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1006-1023. PubMed ID: 29862867
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of new arylazopyrazoles as apoptosis inducers: Candidates to inhibit proliferation of MCF-7 cells.
Ismail MMF; Soliman DH; Sabour R; Farrag AM
Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000214. PubMed ID: 32924168
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel 1,3,4-trisubstituted pyrazole derivatives as potential chemotherapeutic agents for hepatocellular carcinoma.
Harras MF; Sabour R
Bioorg Chem; 2018 Aug; 78():149-157. PubMed ID: 29567429
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic selectivity investigation and 2D-QSAR study of some new antiproliferative pyrazoles and pyrazolopyridines as potential CDK2 inhibitors.
Hassan GS; Georgey HH; Mohammed EZ; George RF; Mahmoud WR; Omar FA
Eur J Med Chem; 2021 Jun; 218():113389. PubMed ID: 33784602
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of 1,3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents.
Reddy TS; Kulhari H; Reddy VG; Bansal V; Kamal A; Shukla R
Eur J Med Chem; 2015 Aug; 101():790-805. PubMed ID: 26231080
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
[TBL] [Abstract][Full Text] [Related]
10. Discovery, synthesis and molecular corroborations of medicinally important novel pyrazoles; drug efficacy determinations through in silico, in vitro and cytotoxicity validations.
Thangarasu P; Manikandan A; Thamaraiselvi S
Bioorg Chem; 2019 May; 86():410-419. PubMed ID: 30769266
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7.
Abdelhaleem EF; Abdelhameid MK; Kassab AE; Kandeel MM
Eur J Med Chem; 2018 Jan; 143():1807-1825. PubMed ID: 29133058
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic induction mediated p53 mechanism and Caspase-3 activity by novel promising cyanoacrylamide derivatives in breast carcinoma.
Mohamed MF; Samir N; Ali A; Ahmed N; Ali Y; Aref S; Hossam O; Mohamed MS; Abdelmoniem AM; Abdelhamid IA
Bioorg Chem; 2017 Aug; 73():43-52. PubMed ID: 28601699
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis.
Vujasinović I; Paravić-Radičević A; Mlinarić-Majerski K; Brajša K; Bertoša B
Bioorg Med Chem; 2012 Mar; 20(6):2101-10. PubMed ID: 22341245
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro Antiproliferative and Antiinflammatory Activities, and Kinase Inhibitory effects of New 1,3,4-triarylpyrazole Derivatives.
El-Gamal MI; Abdel-Maksoud MS; Gamal El-Din MM; Shin JS; Lee KT; Yoo KH; Oh CH
Anticancer Agents Med Chem; 2017; 17(1):75-84. PubMed ID: 27334850
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation, and docking studies of new pyrazole-based thiourea and sulfonamide derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.
Ullah S; El-Gamal MI; Zaib S; Anbar HS; Zaraei SO; Sbenati RM; Pelletier J; Sévigny J; Oh CH; Iqbal J
Bioorg Chem; 2020 Jun; 99():103783. PubMed ID: 32224334
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel α-acyloxy carboxamides via Passerini reaction as caspase 3/7 activators.
Salah Ayoup M; Wahby Y; Abdel-Hamid H; Ramadan ES; Teleb M; Abu-Serie MM; Noby A
Eur J Med Chem; 2019 Apr; 168():340-356. PubMed ID: 30826510
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, cytotoxicity and molecular modeling studies of some novel fluorinated pyrazole-based heterocycles as anticancer and apoptosis-inducing agents.
Fayed EA; Eissa SI; Bayoumi AH; Gohar NA; Mehany ABM; Ammar YA
Mol Divers; 2019 Feb; 23(1):165-181. PubMed ID: 30099687
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, anticancer assessment on human breast, liver and colon carcinoma cell lines and molecular modeling study using novel pyrazolo[4,3-c]pyridine derivatives.
Metwally NH; Deeb EA
Bioorg Chem; 2018 Apr; 77():203-214. PubMed ID: 29367077
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of halogenated phenoxychalcones and their corresponding pyrazolines as cytotoxic agents in human breast cancer.
Halim PA; Hassan RA; Mohamed KO; Hassanin SO; Khalil MG; Abdou AM; Osman EO
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):189-201. PubMed ID: 34894967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
